S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis (2013)
- Authors:
- USP affiliated authors: COGLIATI, BRUNO - FMVZ ; LIMA, FABIANA ROBERTO - HU ; ALVES, VENANCIO AVANCINI FERREIRA - FM ; CARRILHO, FLAIR JOSÉ - FM ; OLIVEIRA, CLAUDIA PINTO MARQUES SOUZA DE - FM
- Unidades: FMVZ; HU; FM
- DOI: 10.2147/DDDT.S43930
- Subjects: CIRROSE HEPÁTICA (ETIOLOGIA); MODELOS ANIMAIS; HEPATOPATIAS; REAÇÃO EM CADEIA POR POLIMERASE; SEQUENCIAMENTO GENÉTICO; BIOQUÍMICA CELULAR
- Language: Inglês
- Imprenta:
- Source:
- Título: Drug Design, Development and Therapy
- ISSN: 1177-8881
- Volume/Número/Paginação/Ano: v. 7, p. 553-563, 2013
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
MAZO, Daniel Ferraz de Campos et al. S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. Drug Design, Development and Therapy, v. 7, p. 553-563, 2013Tradução . . Disponível em: https://doi.org/10.2147/DDDT.S43930. Acesso em: 05 nov. 2024. -
APA
Mazo, D. F. de C., Oliveira, M. G. de, Pereira, I. V. A., Cogliati, B., Stefano, J. T., Souza, G. F. P. de, et al. (2013). S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. Drug Design, Development and Therapy, 7, 553-563. doi:10.2147/DDDT.S43930 -
NLM
Mazo DF de C, Oliveira MG de, Pereira IVA, Cogliati B, Stefano JT, Souza GFP de, Rabelo F, Lima FR, Alves VAF, Carrilho FJ, Oliveira CPMS de. S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Internet]. Drug Design, Development and Therapy. 2013 ; 7 553-563.[citado 2024 nov. 05 ] Available from: https://doi.org/10.2147/DDDT.S43930 -
Vancouver
Mazo DF de C, Oliveira MG de, Pereira IVA, Cogliati B, Stefano JT, Souza GFP de, Rabelo F, Lima FR, Alves VAF, Carrilho FJ, Oliveira CPMS de. S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Internet]. Drug Design, Development and Therapy. 2013 ; 7 553-563.[citado 2024 nov. 05 ] Available from: https://doi.org/10.2147/DDDT.S43930 - Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis
- Experimental models of liver fibrosis
- Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research
- The combination of probiotics and prebiotics supplementation improves lipid metabolism, NAFLD and obesity in ob/ob mice
- Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial
- Survivin expression patterns could reflect different roles in hepatocarcinogenesis, especially in non-alcoholic fatty liver disease-related hepatocellular carcinoma [Carta]
- Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C
- P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC
- Quantification of experimental liver fibrosis with a novel algorithm method based on statistical analysis of signals
- Esteato-hepatite não alcoólica e doença hepática alcoólica
Informações sobre o DOI: 10.2147/DDDT.S43930 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
